| RS1057519544 |
KCNT1
|
Health Risk |
Likely pathogenic |
Malignant migrating partial seizures of infancy, Malignant migrating partial seizures of infancy |
| RS1057519545 |
SYNGAP1
|
Health Risk |
Likely pathogenic |
Epileptic encephalopathy, Epileptic encephalopathy |
| RS1057519546 |
SYNGAP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 5 |
| RS1057519547 |
HCN1
|
Health Risk |
Pathogenic |
Epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1057519548 |
HCN1
|
Health Risk |
Likely pathogenic |
Epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1057519549 |
GABRB3
|
Health Risk |
Likely pathogenic |
Epileptic encephalopathy, Epilepsy |
| RS1057519550 |
GABRB3
|
Health Risk |
Pathogenic/Likely pathogenic |
Epileptic encephalopathy, Epilepsy |
| RS1057519552 |
GRIN2A
|
Health Risk |
Likely pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS1057519558 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1057519559 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1057519560 |
MYT1L
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 39 |
| RS1057519561 |
SNX14
|
Health Risk |
Pathogenic |
Autosomal recessive spinocerebellar ataxia 20, Autosomal recessive spinocerebellar ataxia 20 |
| RS1057519563 |
DENND5A
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 49 |
| RS1057519564 |
DENND5A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 49 |
| RS1057519565 |
DEAF1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 24 |
| RS1057519566 |
MDH2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 51 |
| RS1057519567 |
MDH2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 51 |
| RS1057519568 |
DNAAF6
|
Health Risk |
Pathogenic |
Ciliary dyskinesia, primary |
| RS1057519569 |
DNAAF6
|
Health Risk |
Pathogenic |
Ciliary dyskinesia, primary |
| RS1057519570 |
MYPN
|
Health Risk |
Pathogenic |
MYPN-related myopathy, MYPN-related myopathy |
| RS1057519571 |
MYPN
|
Health Risk |
Pathogenic |
MYPN-related myopathy, MYPN-related myopathy |
| RS1057519573 |
MYPN
|
Health Risk |
Pathogenic |
MYPN-related myopathy, Dilated cardiomyopathy 1KK |
| RS1057519574 |
LRP5
|
Health Risk |
Likely pathogenic |
Osteoporosis with pseudoglioma, Osteoporosis with pseudoglioma |
| RS1057519575 |
LRP5
|
Health Risk |
Likely pathogenic |
Osteoporosis with pseudoglioma, Osteoporosis with pseudoglioma |
| RS1057519576 |
C1R
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, periodontal type 1 |
| RS1057519577 |
C1R
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, periodontal type 1 |
| RS1057519578 |
C1R
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, periodontal type 1 |
| RS1057519579 |
C1R
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, periodontal type 1 |
| RS1057519580 |
C1R
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, periodontal type 1 |
| RS1057519583 |
STN1
|
Health Risk |
Pathogenic |
Cerebroretinal microangiopathy with calcifications and cysts 2, Cerebroretinal microangiopathy with calcifications and cysts 2 |
| RS1057519584 |
KCNQ1
|
Health Risk |
Pathogenic |
Short QT syndrome type 2, Short QT syndrome type 2 |
| RS1057519585 |
NBN
|
Health Risk |
Pathogenic |
Microcephaly, normal intelligence and immunodeficiency |
| RS1057519587 |
NBN
|
Health Risk |
Pathogenic/Likely pathogenic |
Microcephaly, normal intelligence and immunodeficiency |
| RS1057519588 |
NBN
|
Health Risk |
Pathogenic |
Microcephaly, normal intelligence and immunodeficiency |
| RS1057519591 |
CTSD
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis 10, Neuronal ceroid lipofuscinosis |
| RS1057519592 |
TCF4
|
Health Risk |
Likely pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS1057519593 |
KIRREL3
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 4 |
| RS1057519594 |
SETBP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 29 |
| RS1057519595 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome 1, Kabuki syndrome |
| RS1057519596 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1057519597 |
YY1AP1
|
Health Risk |
Pathogenic |
Grange syndrome, Grange syndrome |
| RS1057519598 |
YY1AP1
|
Health Risk |
Pathogenic |
Grange syndrome, Grange syndrome |
| RS1057519599 |
YY1AP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Grange syndrome, YY1AP1-related disorder |
| RS1057519600 |
UCHL1
|
Health Risk |
Pathogenic |
Early-onset progressive neurodegeneration-blindness-ataxia-spasticity syndrome, Early-onset progressive neurodegeneration-blindness-ataxia-spasticity syndrome |
| RS1057519601 |
MYO15A
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS1057519602 |
SGO2
|
Health Risk |
Pathogenic |
Premature ovarian failure, Premature ovarian failure |
| RS1057519603 |
MYO15A
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS1057519604 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS1057519605 |
MYO15A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 3, Hearing loss |
| RS1057519606 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS1057519607 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS1057519608 |
SLC12A1
|
Health Risk |
Pathogenic |
Bartter disease type 1, Bartter disease type 1 |
| RS1057519609 |
GLA
|
Health Risk |
Likely pathogenic |
Fabry disease, Fabry disease |
| RS1057519610 |
SERPINA1
|
Health Risk |
Pathogenic; other |
PI NULL(HONG KONG 1), PI Q0(HONG KONG 1) |
| RS1057519611 |
GRIN2B
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 6 |
| RS1057519612 |
GRIN2B
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 6 |
| RS1057519613 |
SMARCAD1
|
Health Risk |
Pathogenic |
Adermatoglyphia, Basan syndrome |
| RS1057519614 |
SMCHD1
|
Health Risk |
Pathogenic |
Facioscapulohumeral muscular dystrophy 2, Facioscapulohumeral muscular dystrophy 2 |
| RS1057519616 |
MIP
|
Health Risk |
Pathogenic |
Cataract 15 multiple types, Cataract 15 multiple types |
| RS1057519617 |
SCN2A
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant |
| RS1057519622 |
WDR45
|
Health Risk |
Pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS1057519624 |
RPS7
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia 8, Diamond-Blackfan anemia 8 |
| RS1057519626 |
PIEZO2
|
Health Risk |
Pathogenic |
Arthrogryposis, distal |
| RS1057519627 |
SRY
|
Health Risk |
Likely pathogenic |
46, XY sex reversal 1 |
| RS1057519628 |
DYRK1A
|
Health Risk |
Pathogenic |
DYRK1A-related intellectual disability syndrome, DYRK1A-related intellectual disability syndrome |
| RS1057519629 |
TBC1D24
|
Health Risk |
Conflicting classifications of pathogenicity |
Parkinsonian disorder, Developmental and epileptic encephalopathy |
| RS1057519630 |
TBC1D24
|
Health Risk |
Conflicting classifications of pathogenicity |
Parkinsonian disorder, Autosomal dominant epilepsy |
| RS1057519631 |
PTRHD1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with early-onset parkinsonism and behavioral abnormalities, Neurodevelopmental disorder with early-onset parkinsonism and behavioral abnormalities |
| RS1057519632 |
CDK13
|
Health Risk |
Pathogenic |
Congenital heart defects, dysmorphic facial features |
| RS1057519633 |
CDK13
|
Health Risk |
Likely pathogenic |
Congenital heart defects, dysmorphic facial features |
| RS1057519634 |
CDK13
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital heart defects, dysmorphic facial features |
| RS1057519635 |
PRKD1
|
Health Risk |
Pathogenic |
Congenital heart defects and ectodermal dysplasia, Congenital heart defects and ectodermal dysplasia |
| RS1057519636 |
PRKD1
|
Health Risk |
Pathogenic |
Congenital heart defects and ectodermal dysplasia, Congenital heart defects and ectodermal dysplasia |
| RS1057519637 |
HBA2
|
Health Risk |
Pathogenic |
alpha Thalassemia, alpha Thalassemia |
| RS1057519638 |
DMRT1
|
Health Risk |
Likely pathogenic |
46, XY sex reversal 4 |
| RS1057519640 |
SMCHD1
|
Health Risk |
Pathogenic |
Arrhinia with choanal atresia and microphthalmia syndrome, Arrhinia with choanal atresia and microphthalmia syndrome |
| RS1057519641 |
SMCHD1
|
Health Risk |
Pathogenic |
Arrhinia with choanal atresia and microphthalmia syndrome, Arrhinia with choanal atresia and microphthalmia syndrome |
| RS1057519642 |
SMCHD1
|
Health Risk |
Pathogenic |
Arrhinia with choanal atresia and microphthalmia syndrome, Short nose |
| RS1057519643 |
SMCHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhinia with choanal atresia and microphthalmia syndrome, Facioscapulohumeral muscular dystrophy 2 |
| RS1057519644 |
SMCHD1
|
Health Risk |
Pathogenic |
Arrhinia with choanal atresia and microphthalmia syndrome, Facioscapulohumeral muscular dystrophy 2 |
| RS1057519645 |
SMCHD1
|
Health Risk |
Pathogenic |
Arrhinia with choanal atresia and microphthalmia syndrome, Arrhinia with choanal atresia and microphthalmia syndrome |
| RS1057519646 |
SMCHD1
|
Health Risk |
Likely pathogenic |
Arrhinia with choanal atresia and microphthalmia syndrome, SMCHD1-related disorder |
| RS1057519647 |
LDLR
|
Health Risk |
Likely pathogenic |
Hypercholesterolemia, familial |
| RS1057519648 |
LDLR
|
Health Risk |
Likely pathogenic |
Hypercholesterolemia, familial |
| RS1057519649 |
LDLR
|
Health Risk |
Likely pathogenic |
Hypercholesterolemia, familial |
| RS1057519650 |
LDLR
|
Health Risk |
Likely pathogenic |
Hypercholesterolemia, familial |
| RS1057519652 |
LDLR
|
Health Risk |
Likely pathogenic |
Hypercholesterolemia, familial |
| RS1057519653 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1057519654 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1057519655 |
LDLR
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypercholesterolemia, familial |
| RS1057519657 |
LDLR
|
Health Risk |
Likely pathogenic |
Hypercholesterolemia, familial |
| RS1057519658 |
LDLR
|
Health Risk |
Likely pathogenic |
Hypercholesterolemia, familial |
| RS1057519659 |
LDLR
|
Health Risk |
Likely pathogenic |
Hypercholesterolemia, familial |
| RS1057519660 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1057519661 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1057519662 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1057519663 |
LDLR
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS1057519664 |
LDLR
|
Health Risk |
Likely pathogenic |
Hypercholesterolemia, familial |
| RS1057519665 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1057519666 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |